Sign In
Buy ACST
$3.37
+0 (+0%)
At Close: Jan 24, 2025
Acasti Pharma to Report Second Quarter 2023 Financial Results on Monday, November 14, 2022
04:15pm, Monday, 07'th Nov 2022
Call to be held on Monday, November 14th at 1:00 PM Eastern Time Call to be held on Monday, November 14th at 1:00 PM Eastern Time
Acasti Pharma to Participate in the Lytham Partners Fall 2022 Investor Conference
08:15pm, Wednesday, 14'th Sep 2022 GlobeNewswire Inc.
LAVAL, Québec, Sept. 14, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company with drug delivery ca
Acasti Pharma to Participate in the Lytham Partners Fall 2022 Investor Conference
04:15pm, Wednesday, 14'th Sep 2022
LAVAL, Québec, Sept. 14, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company with drug delivery capa
Acasti Pharma to Participate at the H.C. Wainwright 24th Annual Global Investment Conference
09:00am, Monday, 12'th Sep 2022
LAVAL, Québec, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company with drug delivery capa
Acasti Pharma to Report First Quarter 2023 Financial Results on Thursday, August 11, 2022
08:15pm, Tuesday, 02'nd Aug 2022 GlobeNewswire Inc.
Call to be held on Thursday, August 11th at 1:00 PM Eastern Time
Acasti Pharma to Report First Quarter 2023 Financial Results on Thursday, August 11, 2022
04:15pm, Tuesday, 02'nd Aug 2022
Call to be held on Thursday, August 11th at 1:00 PM Eastern Time
Acasti Pharma Announces Annual Grants of Performance Stock Options
10:10pm, Wednesday, 22'nd Jun 2022 GlobeNewswire Inc.
LAVAL, Québec, June 22, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company with drug delivery cap
Acasti Pharma Schedules Fiscal Year 2022 Business Update Conference Call
08:15pm, Thursday, 16'th Jun 2022 GlobeNewswire Inc.
Call to be held on Tuesday, June 21st at 1:00 PM Eastern Time Call to be held on Tuesday, June 21st at 1:00 PM Eastern Time
Acasti Pharma Schedules Fiscal Year 2022 Business Update Conference Call
04:15pm, Thursday, 16'th Jun 2022
Call to be held on Tuesday, June 21st at 1:00 PM Eastern Time Call to be held on Tuesday, June 21st at 1:00 PM Eastern Time
Penny Stocks To Buy Now? 6 To Watch Under $1 This Week
01:48pm, Wednesday, 18'th May 2022 PennyStocks
Penny stocks to watch under $1 today.
The post Penny Stocks To Buy Now? 6 To Watch Under $1 This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Acasti Pharma Announces Positive Results for Pharmacokinetic Bridging Study, With Intravenous GTX-104 Meeting All Endpoints
11:30am, Wednesday, 18'th May 2022 GlobeNewswire Inc.
Bioavailability of IV GTX-104 compared favorably with the oral formulation of nimodipine, and no serious adverse events observed for GTX-104
Acasti Pharma's IV Hemorrhage Drug Candidate At Par With Oral Nimodipine
11:28am, Wednesday, 18'th May 2022
Acasti Pharma Inc's (NASDAQ: ACST) pharmacokinetic (PK) bridging study with IV GTX-104, its lead drug candidate for Subarachnoid Hemorrhage (SAH), met all its planned study endpoints. The study's
Penny Stocks To Buy Now? 6 To Watch Under $1 This Week
09:48am, Wednesday, 18'th May 2022
Penny stocks to watch under $1 today. The post Penny Stocks To Buy Now?
Acasti Pharma to Present at the B. Riley Securities' 2022 Virtual Neuro & Ophthalmology Conference on April 28th
12:30pm, Monday, 25'th Apr 2022 GlobeNewswire Inc.
LAVAL, Québec, April 25, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today announced that Prashant Kohli, Vice President of Comme
Acasti Pharma to Present at the B. Riley Securities' 2022 Virtual Neuro & Ophthalmology Conference on April 28th
08:30am, Monday, 25'th Apr 2022
LAVAL, Québec, April 25, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today announced that Prashant Kohli, Vice President of Commerc
